JP2025513019A5 - - Google Patents
Info
- Publication number
- JP2025513019A5 JP2025513019A5 JP2024559583A JP2024559583A JP2025513019A5 JP 2025513019 A5 JP2025513019 A5 JP 2025513019A5 JP 2024559583 A JP2024559583 A JP 2024559583A JP 2024559583 A JP2024559583 A JP 2024559583A JP 2025513019 A5 JP2025513019 A5 JP 2025513019A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- aryl
- independently
- halogens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22167670 | 2022-04-11 | ||
| EP22167670.3 | 2022-04-11 | ||
| PCT/EP2023/059154 WO2023198597A1 (en) | 2022-04-11 | 2023-04-06 | Rifabutin analogs for the treatment of disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513019A JP2025513019A (ja) | 2025-04-22 |
| JP2025513019A5 true JP2025513019A5 (enExample) | 2026-03-25 |
Family
ID=81306910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559583A Pending JP2025513019A (ja) | 2022-04-11 | 2023-04-06 | 疾患の治療のためのリファブチン類似体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250235434A1 (enExample) |
| EP (1) | EP4508053A1 (enExample) |
| JP (1) | JP2025513019A (enExample) |
| CN (1) | CN118974060A (enExample) |
| AU (1) | AU2023251806A1 (enExample) |
| CA (1) | CA3253889A1 (enExample) |
| WO (1) | WO2023198597A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025132358A1 (en) * | 2023-12-21 | 2025-06-26 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of infectious diseases |
| EP4696694A1 (en) | 2024-08-14 | 2026-02-18 | BioVersys AG | Antibiotic rifabutin analogs |
| EP4696695A1 (en) * | 2024-08-14 | 2026-02-18 | BioVersys AG | Antibiotic rifabutin analogs |
| WO2026062070A1 (en) * | 2024-09-18 | 2026-03-26 | Galapagos Nv | Compounds and pharmaceutical compositions thereof for the treatment of infectious diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262564A (en) | 1992-10-30 | 1993-11-16 | Octamer, Inc. | Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents |
| PT102807A (pt) | 2002-07-09 | 2004-01-30 | Inst Nac De Engenharia E Tecno | Derivados n-substituidos de rifabutina uteis como agentes antimicrobianos, processo para a sua preparacao e sua utilizacao como medicamentos |
-
2023
- 2023-04-06 AU AU2023251806A patent/AU2023251806A1/en active Pending
- 2023-04-06 CA CA3253889A patent/CA3253889A1/en active Pending
- 2023-04-06 CN CN202380032448.9A patent/CN118974060A/zh active Pending
- 2023-04-06 JP JP2024559583A patent/JP2025513019A/ja active Pending
- 2023-04-06 EP EP23718239.9A patent/EP4508053A1/en active Pending
- 2023-04-06 WO PCT/EP2023/059154 patent/WO2023198597A1/en not_active Ceased
- 2023-04-06 US US18/855,839 patent/US20250235434A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025513019A5 (enExample) | ||
| JP7644139B2 (ja) | インダゾール系化合物及び関連使用方法 | |
| JP7548992B2 (ja) | タウタンパク質標的化化合物および関連する使用方法 | |
| CN105601573B (zh) | 2-氨基嘧啶类化合物及其药物组合物和应用 | |
| US11591336B2 (en) | Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors | |
| JP2019512505A5 (enExample) | ||
| WO2022184116A1 (zh) | 新型sos1抑制剂及其制备方法和应用 | |
| JP6162144B2 (ja) | ４，４−二置換−１，４−ジヒドロピリミジン、及びｂ型肝炎の処置のための医薬としてのその使用 | |
| RU2018134981A (ru) | Конъюгаты, содержащие ингибиторы RIPK2 | |
| EP3755699A1 (en) | Shp2 phosphatase inhibitors and methods of use thereof | |
| JP2019123740A (ja) | Ｂｔｋ阻害薬としての一級カルボキサミド類 | |
| IL281188B2 (en) | Polycyclic compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides | |
| TW201011021A (en) | Imidazopyridin-2-one derivative | |
| JP2004505964A5 (enExample) | ||
| WO2008064116A2 (en) | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection | |
| JP2013509431A5 (enExample) | ||
| KR20210121044A (ko) | 치환된 폴리사이클릭 카복실산, 이의 유사체, 및 이의 사용 방법 | |
| JP2019505594A5 (enExample) | ||
| JP2024505558A5 (enExample) | ||
| US9012659B2 (en) | 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment | |
| JP2008517042A5 (enExample) | ||
| AU2023239265A1 (en) | Small molecule inhibitors of tea domain family members | |
| JP2015507004A5 (enExample) | ||
| JP2006511498A5 (enExample) | ||
| JP2025513877A5 (enExample) |